Uveitis Treatment Market: Steady Growth Expected With A 5.8% CAGR Through 2034
Uveitis Treatment Market Analysis of Uveitis Treatment Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, ...
Hosted on MSN18d
Eye Treatment Shows Early Promise In Treating Uveitis In Horses, And Could Help Humans
If caught early, medicine can prevent uveitis from causing loss of eyesight, but in more advanced cases, the damage is already done, said Lauren Stewart Stafford, a former UF/IFAS microbiology and ...
Ophthalmology Times1d
Preclinical study of KIO-104 in a proliferative vitreoretinopathy model accepted for poster presentation at ARVO 2025
The findings of this model support KIO-104 as a promising therapeutic candidate for both the prevention and treatment of PVR.
Kiora Pharmaceuticals to Present Preclinical Data on KIO-104 for the Treatment of Proliferative Vitreoretinopathy at the ARVO 2025 Annual Meeting
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced their abstract of a preclinical study of KIO ...
ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label
ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to ...
AFP14d
TEVIMBRA Approved in U.S. for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma in Combination with Chemotherapy
Ocular: Uveitis, iritis, and other ocular inflammatory toxicities ... serious complications can occur in patients who receive allogeneic hematopoietic stem cell transplantation (HSCT) before or after ...
Business Wire14d
TEVIMBRA Approved in U.S. for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma in Combination with Chemotherapy
Ocular: Uveitis, iritis, and other ocular inflammatory ... can occur in patients who receive allogeneic hematopoietic stem cell transplantation (HSCT) before or after being treated with a PD ...
Frontiers9d
Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis
The HLA-B27 Ankylosing Spondylitis and Acute Anterior Uveitis Atlas (BASSAA) (currently in Beta v0.4) is a web application built on the Shiny platform to visualize single-cell RNA/CITE sequencing data ...